InterBioScreen
Ltd.
"Scientific Partnership"
Charity Foundation
Russian Academy of Sciences
National Academies of Sciences of CIS countries
|
InterBioScreen
Ltd. |
II
International Conference
Chemistry and Biological Activity
of Oxygen- and Sulfur-Containing Heterocycles
October 14-17, 2003 Moscow, Russia
 |
Russian State Academy
of Civil Service
(under the President of Russian Federation)
ROUTE
InterBioScreen Ltd., Charitable foundation Scientific Partnership, National Academies of Sciences of CIS countries, and Russian Academy of Sciences are planning to continue international meetings of the Russian and CIS researchers active in the field of the chemistry and biological activity of synthetic and natural heterocyclic compounds (CBC).
The previous meeting CBC 2001 was held in Russia (Moscow, 2001). The conference has assembled the "best of the best" and become the most representative forum of the leading scientists from all regions across Russia and C.I.S. states (Ukraine, Belarus, Kazakhstan, Uzbekistan, Georgia, Tajikistan, Kirghizia, Latvia).
II International Conference
on the Chemistry and Biological Activity of Oxygen- and Sulfur-Containing
Heterocycles
will be held on
October 14-17, 2003 in Moscow.
Prof. Elias J.Corey (Greeting letter)
USA, the Nobel Prize in Chemistry 1990
Harvard Dept. of Chemistry&Chemical Biology University Hall, USA
Prof. Ryoji Noyori (Greeting letter)
Japan, the Nobel Prize in Chemistry 2001
Dept. of Chemistry Graduate School of Science, Research Center of Materials Science Nagoya University, Japan
Prof. Rolf Huisgen
Institut fur Organische Chemie der Ludwig-Maximilians Universitat Munchen, Germany
Prof. Alan Katritzky
Dept. of Chemistry, University of Florida,USA
Prof. Henk C.van der Plas
Lab. of Organic Chemistry, University of Wageningen,The Netherlands
Prof. Jan Bergman
Dept. of Organic Chemistry, CNT, Novum, Sweden
The intention of the conference organizers is to provide a unique forum to discuss the developments and the key issues faced by the interdisciplinary scientific community engaged in the research into biologically active compounds.
|
|
|